Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter and Conference Paper
Missense Mutations at ALA-10 in the Factor IX Propeptide: A Novel Mechanism for Severe Bleeding During Oral Anticoagulant Therapy
Bleeding complications represent the most common and unwanted side effect of oral anticoagulant therapy. We present a novel mechanism for bleeding during coumarin therapy, attributed to newly described missens...
-
Article
Severe bleeding in two patients due to increased sensitivity of factor IX activity to phenprocoumon therapy
Two male patients with severe and recurrent bleeding episodes under phenprocoumon therapy are reported. Both patients exhibited a strong decrease of their factor IX activities below 1% of normal, whereas the ...